Temporary reversal of anticoagulation using oral vitamin K

Richard H White, S. M. Minton, M. D. Andya, R. Hutchinson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Brief reversal of oral anticoagulant therapy is frequently necessary prior to minor surgery or invasive procedures. We sought to determine the effect of an oral dose of 2.0 mg of vitamin K1 on the international normalized ratio (INR) among patients with a stable therapeutic INR who were maintained on their daily dose of warfarin. We prospectively studied a convenience cohort of patients attending an anticoagulation clinic who had either just completed treatment for venous thromboembolism or were receiving prophylaxis for atrial fibrillation, cardiomyopathy, or peripheral vascular disease. Each patient received an oral dose of 2.0 mg of aqueous vitamin K1. Serial INR measurements were taken over 1 week. There was wide variation in the INR response between patients, from no change to complete reversal of anticoagulation. The effect also varied widely over time. There was a significant inverse correlation between the fall in logarithm of the INR and the daily warfarin dose required to achieve an INR value of 2.5 (r = -0.52, p = 0.011). Use of a 2.0 mg oral dose of vitamin K1 does not reliably reverse (correct) a therapeutic INR in patients maintained on their daily dose of warfarin.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalJournal of Thrombosis and Thrombolysis
Volume10
Issue number2
StatePublished - 2000

Fingerprint

International Normalized Ratio
Vitamin K
Vitamin K 1
Warfarin
Minor Surgical Procedures
Peripheral Vascular Diseases
Venous Thromboembolism
Therapeutics
Cardiomyopathies
Anticoagulants
Atrial Fibrillation

Keywords

  • Anticoagulation
  • INR
  • Vitamin K
  • Warfarin

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

White, R. H., Minton, S. M., Andya, M. D., & Hutchinson, R. (2000). Temporary reversal of anticoagulation using oral vitamin K. Journal of Thrombosis and Thrombolysis, 10(2), 149-153.

Temporary reversal of anticoagulation using oral vitamin K. / White, Richard H; Minton, S. M.; Andya, M. D.; Hutchinson, R.

In: Journal of Thrombosis and Thrombolysis, Vol. 10, No. 2, 2000, p. 149-153.

Research output: Contribution to journalArticle

White, RH, Minton, SM, Andya, MD & Hutchinson, R 2000, 'Temporary reversal of anticoagulation using oral vitamin K', Journal of Thrombosis and Thrombolysis, vol. 10, no. 2, pp. 149-153.
White, Richard H ; Minton, S. M. ; Andya, M. D. ; Hutchinson, R. / Temporary reversal of anticoagulation using oral vitamin K. In: Journal of Thrombosis and Thrombolysis. 2000 ; Vol. 10, No. 2. pp. 149-153.
@article{9ff300e9e43640a7b2065301af7de3b4,
title = "Temporary reversal of anticoagulation using oral vitamin K",
abstract = "Brief reversal of oral anticoagulant therapy is frequently necessary prior to minor surgery or invasive procedures. We sought to determine the effect of an oral dose of 2.0 mg of vitamin K1 on the international normalized ratio (INR) among patients with a stable therapeutic INR who were maintained on their daily dose of warfarin. We prospectively studied a convenience cohort of patients attending an anticoagulation clinic who had either just completed treatment for venous thromboembolism or were receiving prophylaxis for atrial fibrillation, cardiomyopathy, or peripheral vascular disease. Each patient received an oral dose of 2.0 mg of aqueous vitamin K1. Serial INR measurements were taken over 1 week. There was wide variation in the INR response between patients, from no change to complete reversal of anticoagulation. The effect also varied widely over time. There was a significant inverse correlation between the fall in logarithm of the INR and the daily warfarin dose required to achieve an INR value of 2.5 (r = -0.52, p = 0.011). Use of a 2.0 mg oral dose of vitamin K1 does not reliably reverse (correct) a therapeutic INR in patients maintained on their daily dose of warfarin.",
keywords = "Anticoagulation, INR, Vitamin K, Warfarin",
author = "White, {Richard H} and Minton, {S. M.} and Andya, {M. D.} and R. Hutchinson",
year = "2000",
language = "English (US)",
volume = "10",
pages = "149--153",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Temporary reversal of anticoagulation using oral vitamin K

AU - White, Richard H

AU - Minton, S. M.

AU - Andya, M. D.

AU - Hutchinson, R.

PY - 2000

Y1 - 2000

N2 - Brief reversal of oral anticoagulant therapy is frequently necessary prior to minor surgery or invasive procedures. We sought to determine the effect of an oral dose of 2.0 mg of vitamin K1 on the international normalized ratio (INR) among patients with a stable therapeutic INR who were maintained on their daily dose of warfarin. We prospectively studied a convenience cohort of patients attending an anticoagulation clinic who had either just completed treatment for venous thromboembolism or were receiving prophylaxis for atrial fibrillation, cardiomyopathy, or peripheral vascular disease. Each patient received an oral dose of 2.0 mg of aqueous vitamin K1. Serial INR measurements were taken over 1 week. There was wide variation in the INR response between patients, from no change to complete reversal of anticoagulation. The effect also varied widely over time. There was a significant inverse correlation between the fall in logarithm of the INR and the daily warfarin dose required to achieve an INR value of 2.5 (r = -0.52, p = 0.011). Use of a 2.0 mg oral dose of vitamin K1 does not reliably reverse (correct) a therapeutic INR in patients maintained on their daily dose of warfarin.

AB - Brief reversal of oral anticoagulant therapy is frequently necessary prior to minor surgery or invasive procedures. We sought to determine the effect of an oral dose of 2.0 mg of vitamin K1 on the international normalized ratio (INR) among patients with a stable therapeutic INR who were maintained on their daily dose of warfarin. We prospectively studied a convenience cohort of patients attending an anticoagulation clinic who had either just completed treatment for venous thromboembolism or were receiving prophylaxis for atrial fibrillation, cardiomyopathy, or peripheral vascular disease. Each patient received an oral dose of 2.0 mg of aqueous vitamin K1. Serial INR measurements were taken over 1 week. There was wide variation in the INR response between patients, from no change to complete reversal of anticoagulation. The effect also varied widely over time. There was a significant inverse correlation between the fall in logarithm of the INR and the daily warfarin dose required to achieve an INR value of 2.5 (r = -0.52, p = 0.011). Use of a 2.0 mg oral dose of vitamin K1 does not reliably reverse (correct) a therapeutic INR in patients maintained on their daily dose of warfarin.

KW - Anticoagulation

KW - INR

KW - Vitamin K

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=0033760691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033760691&partnerID=8YFLogxK

M3 - Article

C2 - 11005937

AN - SCOPUS:0033760691

VL - 10

SP - 149

EP - 153

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 2

ER -